In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Cardinal Health’s current price trades significantly below a high-confidence fair value average of $453.72, implying notable upside potential. Monte Carlo analysis reveals zero downside risk scenarios below the current price, with a wide valuation range reflecting elevated volatility and growth uncertainty. Weak profitability and growth scores contrast sharply with strong leverage, signaling structural financial risks amid potential undervaluation.